ABSTRACT Genomics promises to revolutionize the study of nutrient function and requirements and, thereby, solidify the connection of this field to basic sciences, such as molecular genetics. In this short review, we address the general concepts and techniques used in high throughput measurements of gene expression. We also speculate on how these technologies can be used to further our understanding of basic metabolism and nutrient regulation of gene expression in developmental and pathological conditions. J. Nutr. 131: 1605S-1609S, 2001.
Central to the field of nutrition are the questions of how we metabolize and utilize food and how nutritive components in food modulate cellular functions. A shortcoming in any study focusing on these issues is the genetic heterogeneity in the population: what is beneficial for one person may be life threatening for another. The advent of deoxyribonucleic acid (DNA) 4 microarray technologies is now permitting systematic approaches that will enable the characterization of nutrient metabolism and function between population groups and perhaps among individuals within a group. This technology will have a profound effect on basic nutritional research, disease diagnosis, drug development and engineering of therapeutics to alleviate nutritional disorders. This review will focus on how the use of microarray technologies will speed our understanding of all facets of nutrition-based research.
DNA microarray technologies
Defining the tools. Since the advent of gene cloning, scientists have gained much insight into the control of cellular behavior by studying the regulation of individual genes. However, understanding how one's favorite gene is coordinately regulated among thousands of genes within the cellular microenvironment has only become possible within the last several years. Microarray technology provides a forum for such studies. Microarray analysis has also enabled researchers to move beyond understanding how a specific stimulus regulates a specific gene or set of genes in a pathway and toward understanding how such stimuli modulate many regulatory pathways in concert.
Successful utilization of such powerful technology begins with the creation of an ordered set of nucleotide sequences, an array of DNA. DNA microarrays can be produced in various forms, some examples of which are shown in Figure 1 . DNA arrays can be synthesized using photochemical techniques or with ink jet technology (Marton et al. 1998) . These arrays will eventually accommodate the entire population of genes carried within the human genome, but, currently, the most instructive experiments have been performed with the complete set of yeast genes.
Once a DNA microarray is synthesized, it is hybridized with ribonucleic acid (RNA) that has been converted into fluorescently labeled probes either as double-stranded complimentary DNA (cDNA) or single-stranded copy RNA. In a typical cDNA microarray experiment, two RNA samples (from control and experimental tissue) are labeled with two different fluorescent dyes that can be distinguished using a high-resolution scanner. The labeled probes are hybridized to the same chip and differential gene expression is observed as differing ratios of signal from the two fluors (Lockhart and Winzeler 2000) . Researchers have observed differential signal depending on the fluorescent tag used, so it is often necessary to repeat the hybridizations after switching the fluorescent tags on the control and experimental RNA samples.
In the case of the GeneChip (Affymetrix, Inc., Santa Clara, CA), a single RNA sample is converted into a fluorescent probe and hybridized to a single chip, and the signal is also read using a fluorimager device (Lockhart and Winzeler 2000) . Several hybridization controls are used to generate normalized expression levels that allow comparison of RNA levels among different GeneChips. Both approaches require highly reproducible methods that must be validated empirically by hybridizing the same probe to two different chips and comparing the observed expression levels. This control experiment gives the investigator an indication of the variability of the system and is expressed as the lowest fold difference that is considered reliable; a twofold difference is usually the lower limit. The cDNA microarray approach lends itself to pair-wise comparisons, as mentioned, control versus experimental (red vs. green in Fig.  2) . However, as long as an appropriate control sample is available, multiple experimental samples can be analyzed (i.e., mock-treated cells at T ϭ 0 and at 1 h vs. cells treated with compounds X or Y at T ϭ 0 and at 1 h). Typically, replicate chips are hybridized with the same probes and the values averaged. Because of the computer controlled on-chip synthesis method for the oligonucleotide array, as opposed to the spotting of polymerase chain reaction products for the cDNA array chips, the results from a GeneChip experiment typically have lower error rates (Lipshutz et al. 1999) . In addition, the creation of cDNA arrays often depends on expressed sequencing tag-sequencing results to define singleton clones (i.e., nonredundant spots on the slide). Because of the inherent variability in expressed sequencing tag sequence data, results from cDNA microarrays can require resequencing of clones to determine identity and uniqueness of genes of interest, which can be laborious when large numbers of clones are involved (Lipshutz et al. 1999) .
Once the fluorescence images are obtained, the work of analyzing the data starts (Fig. 3) . The images of fluorescence levels (Fig. 2 ) are processed and normalization performed to control for variability in probe quality. The results from both arrays can be expressed as change in expression levels relative to control for each gene or probe set. It is then possible to sort the data and construct clusters of genes that display coregulation. In the example shown at the bottom of Figure 2 , red indicates genes whose expression has increased, black is unchanged and green is reduced relative to control. The red rows are clusters of genes that are responding in a similar manner, in one case, to only one treatment, and in another case, to two different treatments. This type of clustering allows the investigator to determine which genes are regulated in the same manner, suggesting relatedness. The identities of the genes within a cluster can then lead to insights into the cell's response to the experimental condition. The real power of large-scale gene expression experiments is not the creation of lists of regulated genes, but it is a view of changes in biochemistry on a grand scale. The yeast GeneChip, with nearly all of the yeast open reading frames represented, makes it possible to observe effects on an entire genome under a given condition (Wodicka et al. 1997 ). This type of perspective requires a substantial amount of time to analyze fully all of the changes; an example is given below. In some cases, hundreds or even thousands of genes are affected in an experiment. As more and more microarray experiments are performed and the results compiled, we may begin to see commonalities and differences in how cells integrate signals and modify responses.
Experimental concerns. Use of DNA microarrays, both oligonucleotide-and cDNA-based, presents a researcher with novel issues. These issues can be summarized in the following statement: when a researcher obtains a list of regulated genes as output from a chip experiment, that list may contain from a few tens upward to a few thousand genes. Thus, it is not always practical to confirm all of the putative changes in gene expression. Therefore, it is important to anticipate sources of error beforehand. A common practice to minimize sample-to-sample variability is to perform replicate experiments and then to pool RNA samples for each treatment from each replicate sample. These pooled RNA samples are then used to produce the labeled probes. Because of variability in the production of cDNA arrays, at least four replicate arrays typically are used per hybridization and the values for each spot are averaged. The oligonucleotide arrays tend to have fewer errors and the need for replicate hybridizations is also less; in some cases, no replicate hybridizations are performed. Finally, it is very important that control samples are matched as precisely as possible to experimental samples so that any changes in expression can be specifically attributed to the treatment and not to mechanical error. For example, a proposed experiment may require the use of two different incubators that have slightly different carbon dioxide levels. If the experimental sample is in one incubator and the control sample is in the other, an investigator could be mislead into thinking that a large cluster of genes is regulated by the treatment, but, in fact, they are responding to different levels of carbon dioxide.
Although it is tempting to get caught up in ensuring the accuracy of microarray expression data, it should be noted that the true power of genome-wide expression monitoring is not the listing of relative RNA levels, but rather the predictive value that such information has on the physiological responses being studied. Thus, the gold being mined from the data is which pathways are showing transcriptional control under the experimental conditions and that typically depends on the response of several genes, minimizing the impact of slight inaccuracies of the estimation of expression from any one gene. Once the researcher has defined the transcriptional responses at play in a given experiment, those conclusions are the basis for the next set of experiments that should be performed and it is the outcome of those next experiments that confirms the projections of the expression data (Harmer et al. 2000) .
Using the tools
No hypothesis needed. Although this concept may be heretical (particularly to individuals in medical fields), microarray analysis is one illustration that important insights can be gained from the systematic production of simple kinds of biological information without a central hypothesis (Brent 2000) . The ongoing microarray research is often observational rather than experimental and, as we mentioned above and demonstrate in an example below, the findings FIGURE 1 Production of cDNA and oligonucleotide arrays. Synthesis of the cDNA arrays starts with a collection of unique clones. Each clone is polymerase chain reaction amplified and the product spotted using robotics onto glass slides. Oligo arrays start with a database of gene sequence; the sequence data are used to design sets of oligos that are gene specific. In the case of GeneChips, the oligos are synthesized directly on the silicon chip using photolithography. It is also possible to spot out synthesized oligos onto a glass slide in the same manner as the cDNA arrays.
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Common applications. Regardless of whether the experiments begin with a specific hypothesis or a fishing rod, the desired endpoints of microarray-based endeavors can be roughly divided into two categories: determination of genotype and analysis of differential gene expression.
Microarray-based genotype analysis involves the isolation of DNA from an experimental sample, and comparison of its genetic code with that of a defined control sample. To detect single base pair changes in a gene of interest (i.e., polymorphisms), the probe must consist of oligonucleotides representing permutations of this gene. Some sequence alterations will be associated with aberrant gene function; some will represent benign changes. The hybridization pattern of the sample DNA with the probe will reveal the presence of, or propensity to develop, a specific disease. This approach has been successfully applied to the prediction/detection of various pathologies for which causal gene mutations have been defined, most notably, cancer (Wang et al. 1998 , Wen et al. 2000 , Lehman et al. 2000 .
A more common application of microarray technology in basic and clinical research is the detection of differences in gene expression between and among samples (or populations of samples). As described above, these analyses require messenger RNA isolation from experimental and control samples, which are then reverse-transcribed, and levels of resulting cDNA compared. Similarities and differences in gene expression can be equally instructive depending on the research question.
This approach has been successfully used for gene discovery (i.e., new genes in a characterized gene family or known regulatory pathway) and is similarly used by pharmaceutical companies for drug discovery (Scherf et al. 2000) . Pharmacologists and toxicologists alike have taken advantage of this approach to understand individual and population variances in physiological response and sensitivity to particular compounds ).
In the past, drug discovery was a long and arduous task. Initially, a biochemical pathway was implicated in a pathophysiological process. Armed with potential insights about the enzymes that are required for a functional pathway, biochemists and medicinal chemists would collaborate to identify and optimize the therapeutic behavior of candidate molecules that bind to specific target enzymes. Clinical trials then identified the candidate molecules with therapeutic efficacy in human subjects. This "needle in a haystack" approach costs $50 to $500 million for each new drug brought to market. DNA microarray methods promise to streamline many of these steps.
Indeed, microarray analysis is currently being incorporated into many steps in drug development, including target identification and validation (demonstrating that affecting the enzyme or biochemical process has therapeutic utility), optimization of efficacy and reduction of toxicity (Roses 2000) . A promise of this emerging technology is that medical professionals will be able to select the most effective drugs, or those with the fewest side effects, for individual patients. DNA microarray analysis also will facilitate identification of prospective clinical trail participants who might be expected to respond optimally or adversely to specific therapeutics.
Applications in nutrition research. The technology necessary to perform elaborate DNA microarray analysis and to analyze the vast data sets currently is perceived as prohibitively expensive by most academic scientists. At present, the majority of DNA microarray data are being generated in corporations; these data have been slow in finding their way into the public domain. However, this technology is becoming more broadly accessible, as indicated by the large increase in the number of published studies involving data obtained from array analyses. Ultimately, the field of nutrition will be fundamentally changed by molecular genetics, the availability of massive FIGURE 2 Steps in a microarray experiment. The methods for using cDNA and oligonucleotide arrays are much the same. A typical image is shown for a cDNA array, green and red spots indicate genes that are specifically expressed in only one treatment, yellow indicates genes expressed equally in both (yellow ϭ mix of red and green). An image from an oligo array is shown, a single fluorescent tag is used and the level of fluorescence for a set of oligos is taken as the expression level for that gene. Processed data are showed as colored bars representing expression levels for a given gene, aligned in a column and each treatment is a different row. Red indicates increased expression, black is unchanged and green is reduced, all relative to a control sample.
FIGURE 3
Overview of the information processing required for large-scale gene expression experiments. Genomics-based gene expression experiments require large, well-integrated information handling systems. Databases of sequences are required for the synthesis of the arrays; those sequences or clones must be tracked accurately throughout the process. Computer systems are required for each step, from the synthesis of the arrays, to image acquisitions and of course data analysis and processing. Many array experiments are performed using a core facility and the data become part of a data warehouse. These warehouses can then be queried for information on a particular gene and/or pathway in vertical searches that integrate data from many experiments.
amounts of DNA sequence information and the development of technologies to exploit its use, such as microarray analysis.
Consider the power of using a series of mouse mutants consuming a diet of well-defined plant mutants (Fink 1998) . Using comparative microarray technologies with these precise genetic backgrounds, one can define the specific nutrients that promote vitality and longevity and their molecular targets. For example, one might find that a particular set of genes is always activated in a specific mouse mutant that dies of coronary artery disease when fed a wild-type plant. However, this same animal exhibits no induction of these genes and survives without complications when fed a mutant plant unable to produce a particular lipid. The ability to perform such exact feeding studies would transform heterogeneous nutrition feeding studies into an exact science.
Although these types of experiments in humans may seem like science fiction, they are already being achieved in simple models systems, with well-defined genomes, such as the budding yeast Saccharomyces cerevisiae. A recent example is a study by Lyons et al. (2000) that used DNA microarray analysis to identify the yeast genes involved in zinc homeostasis.
Previously, the same investigators had identified a transcription factor Zap1p that senses cellular zinc status and increases expression of target genes in response to zinc deficiency (Zhao et al. 1998) . They also found the zinc-responsive DNA element (ZRE) within the promoter region of these target genes (Zhao and Eide, 1997) . In their recent study, the authors performed three individual experiments that combined the elegant yeast genetic system with state-of-the-art DNA microarray analysis (Fig. 4) . First, using DNA microarrays, they determined that 15% of the genes in yeast are significantly altered by changing the zinc content of the media; 458 yeast genes are more highly expressed in zinc-deficient media. The second experiment used genetic analysis in combination with DNA microarrays. They compared the ability of wild-type yeast strains and Zap1-deficient yeast strains to alter gene expression in response to zinc deficiency. This experiment revealed that 214 genes are more highly expressed in the wild-type strain, which suggests that these genes require functional Zap1p for expression. Of these 214 genes, 111 of these overlap with the 476 genes induced during zinc deficiency. Next, the investigators used a computer program to scan the promoter region of these 111 genes for any putative ZRE elements. This approach identified 46 genes that overlap with the 111 genes identified in the previous two experiments.
The authors were able to confirm the fidelity of this approach by monitoring the expression of several of these genes using a reporter construct. In each case, the reporter construct required Zap1p and zinc deficiency for optimal expression. Thus, the microarray data are in agreement with standard approaches, demonstrating that these genes are regulated by Zap1 during zinc deficiency. This analysis provided proof that arrays can serve as powerful substitutes for conventional methods of evaluating messenger RNA abundance.
A decade ago, a relatively small set of genes, thought to be important in zinc homeostasis, would have been included in an array. These types of experiments would not use the full potential of the array. A major advantage of using arrays, especially those that contain probes for the entire genome (such as the yeast chips used in this study), is that it is not necessary to guess what the important genes or mechanisms are in advance. Instead of testing a hypothesis, a broader, more thorough and less biased view of the cellular response is obtained (Lockhart and Winzeler 2000) .
The impressive list of Zap1 target genes generated in this study illustrates the elegance of combining microarray expression profiling with computer analysis. Only a handful of genes involved in zinc homeostasis have been identified by classical genetic studies in yeast. This novel combined approach enabled the discovery of new genes that could not be identified by mutant analysis alone.
It is important to bear in mind that this study has no immediate functional significance. It simply suggests that genes, regulated by Zap1p in a zinc-responsive manner, may be involved in zinc homeostasis. More than 50% of the genes identified in this study have no known function. However, by using the tools available in yeast, it will be a relatively straightforward procedure to analyze the mutant phenotype of these genes individually and in combinations.
Another potential use of microarray technology in the field of nutrition science is analogous to that of pharmacological or toxicological studies in which nutritive components of foods are viewed as drugs. By studying the cellular and molecular reaction to specific nutrients, in specific doses, between population groups and among individuals within those groups, one can begin to define the optimal cellular doses to produce the desired molecular responses in a given subpopulation.
For the field of nutrition to adequately harness the powerful tools of genomic biology, it is imperative that collaborations be formed with plant biologists, mathematicians, engineers and computer scientists. With the proper design and implementation of microarray experiments, these expression profiles will provide the basis for understanding how nutrients affect gene expression to orchestrate the function of organisms (Young 2000) . By capturing genetic pathways in computational form, the field of nutrition can augment the understanding of the metabolic pathways that are the benchmark of nutritional sciences. These genetic and metabolic pathways then can be manipulated through diet, environmental stimuli and genetic targeting.
FIGURE 4
A diagramatic representation of the approach taken by Lyons et al. (2000) to identify Zap1p target genes. Zap1 is a transcription factor that senses cellular zinc status. ZRE is a zinc-responsive DNA element found in the promoter region of genes regulated by Zap1. The complete data set is available on the Internet at: http://genome-www .stanford.edu/zinc. WT indicates wild type.
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